Philips Medical Solutions wants operators of its MR scanners to work smarter, not harder. To help, the company developed SmartExam.
Philips Medical Solutions wants operators of its MR scanners to work smarter, not harder. To help, the company developed SmartExam.
Technology unveiled at the RSNA meeting in December automates the planning, scanning, and processing of MR scans. This decreases overall exam time, while increasing consistency and reliability, according to the company. The algorithm runs on all Philips MR systems.
The process begins with settings stored in Philips' ExamCards, which are customized for individual exams. SmartExam automatically detects anatomic landmarks in a survey scan of the patient, then plans the diagnostic scans related to the patient's actual position in the magnet.
The operator defines the spatial resolution, and SmartExam does the rest, according to Philips, automatically maintaining resolution and image contrast regardless of variations in the field-of-view.
Other MR enhancements shown at the Philips booth include diffusion body scanning, which is designed to improve detection of lesions throughout the body. 4D-TRAK MR Angiography (4D time-resolved angiography using keyhole) makes MR angiography up to 60 times faster. It allows the visualization, for example, of feeding and draining arteries and veins in arteriovenous malformations.
FiberTrak visualizes white matter fibers in the brain, providing a map that neurosurgeons can use to avoid or minimize damage to the neurologic pathways that control speech and movement. Another feature, k-t BLAST, boosts the speed of cardiac MR by a factor of five, reducing scan times for the heart and making cine cardiac MRI in a single breath-hold a reality.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.